Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response (Q35448239)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 1, 1995
edit
Language Label Description Also known as
English
Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response
scientific article published on November 1, 1995

    Statements

    Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit